Answers are grounded in this paper and cite their sources.
THE chemotherapeutic agent Myleran has been under investigation for the treatment of leukemia during the past five years. This compound, 1:4 - dimethanesulfonyloxybutane (CH3SO2OCH2CH2CH2CH2OSO2CH3), which was synthesized by Timmis1 in 1950, had an intense inhibitory effect on the growth of the Walker rat carcinoma 256 as well as a depressive influence on the myeloid series both in the rat and in man. Haddow and Timmis1 showed that the main depressant action of Myleran was on circulating neutrophils in rats. This led to its trial . . .
No takes yet. Share an insight, caveat, or question.
Unugur et al. (1957) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: